Our present study utilizing in vitro and in vivo approaches shed light on the biology of ATF4/HO-1 pathway in regulating autophagy and apoptosis in renal podocytes in DN and suggests beneficial therapeutic effect of HO-1 agonist hemin in treating diabetic nephropathy. This evidence concerns the gene HMOX1 and liver dysplastic nodule.